Try our Advanced Search for more refined results
Life Sciences - March, 2004
33 articles
- Tyco Ordered To Pay $135M In Patent Suit
- Judge Rules For Cytomedix In Patent Suit Over Platelet Releasates
- TKT Regains European Rights to Dynepo
- Court Rules Mylan Infringes J&J Duragesic Patent
- Benitec Sues Biotech Rivals Over RNAi Gene Silencing Technology
- Canada Committee Reviews Draft Of Landmark Generics Bill
- Endo Gets 180-Day Market Exclusivity For OxyContin
- Mylan Sues Procter & Gamble and Watson Over "Authorized Generic"
- Andrx Relinquishes 180-Day Exclusivity For Wellbutrin Generic, Ceding Ground To Eon
- Shire Buys Fosrenol Patent Rights for Up to $31 M
- Dr. Reddy's Files FDA ANDA For UCB Epilepsy Drug
- Glaxo Loses Patent For Seretide/Advair In U.K.
- Bingham McCutchen Hires IP Attorneys In New York, Eyes Further Expansion
- Judge Rules For Abbott In Depakote Patent Suit Vs. Apotex Unit
- Aventis Faces Threat Of Generic Competition For Lovenox
- Pfizer Halts Ranbaxy's Diflucan Generic With Court Ruling
- E.U. Pharmaceutical Reform Package Comes Into Effect
- Glaxo Eyes Court Ruling On Seritide Patent
- ArthroCare Wins Permanent Injunction Against Smith & Nephew in Patent Infringement Lawsuit
- Pfizer To Sue Drug Maker Seeking FDA OK To Market Generic Detrol
- Aventis Files Additional Suits Over Allegra Patents
- GSK Sues Bentley In Spain Over Paxil Generic
- EPO Board of Appeal OKs Agennix Patent Claims
- FDA OKs Generic Version Of Abbott's Tricor By Impax, Teva
- IMPAX Receives Final FDA Approval for Generic Version of Claritin-D 24-Hour
- Diomed Expands Litigation Vs. Vascular Solutions With Patent Suit
- Roche Diagnostics Sues Rivals Over Blood Glucose Monitors
- Australian Commission Proposes Amendments To Patent Law For Genetic Research
- FDA To Disclose Dates Of Complete Generic Applications
- Judge Sets Deadline for Post-Trial Briefs In Zyprexa Case
- Trade Group Blasts "Authorized Generic" Deals
- Biogen Idec Pays $20M To Settle Patent Suit With Corixa, GSK
- Brisk Start For U.S. Trademark Applications Under Madrid Protocol